A detailed history of Bcs Wealth Management transactions in Amgen Inc stock. As of the latest transaction made, Bcs Wealth Management holds 793 shares of AMGN stock, worth $209,518. This represents 0.11% of its overall portfolio holdings.

Number of Shares
793
Previous 793 -0.0%
Holding current value
$209,518
Previous $248,000 3.23%
% of portfolio
0.11%
Previous 0.12%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

BUY
$262.75 - $319.31 $208,360 - $253,212
793 New
793 $248,000
Q4 2023

Jan 11, 2024

BUY
$255.7 - $288.46 $177,200 - $199,902
693 New
693 $200,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Bcs Wealth Management Portfolio

Follow Bcs Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bcs Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Bcs Wealth Management with notifications on news.